What Happened?
, -based Avidity Biosciences Appointed Cheryl Crook as Associate Director, Human
Date of management change: April 10, 2023
, -based Avidity Biosciences Appointed Cheryl Crook as Associate Director, Human
Avidity Biosciences, Inc.`s mission is to profoundly improve people`s lives by delivering a new class of RNA therapeutics - Antibody Oligonucleotide Conjugates (AOCs™). Avidity`s proprietary AOCs are designed to combine the specificity of monoclonal antibodies with the precision of oligonucleotide therapies to target the root cause of diseases previously untreatable with RNA therapeutics. Avidity`s advancing and expanding pipeline has three programs in clinical development. AOC 1001 is designed to treat people with myotonic dystrophy type 1 (DM1) and is currently in Phase 1/2 development with the ongoing MARINA™ and MARINA-OLE™ trials. AOC 1020 is designed to treat people living with facioscapulohumeral muscular dystrophy (FSHD) and is currently in Phase 1/2 development with the FORTITUDE™ trial. AOC 1044 is designed for people with Duchenne muscular dystrophy (DMD) mutations amenable to exon 44 skipping and is currently in Phase 1/2 development with the EXPLORE44™ trial. AOC 1044 is the first of multiple AOCs the company is developing for DMD. Avidity is also broadening the reach of AOCs beyond muscle tissues through both internal discovery efforts and key partnerships as the company continues to deliver on the RNA revolution. Avidity is headquartered in San Diego, CA.
Cheryl Crook is Associate Director, Human at Avidity Biosciences. Previously, Cheryl held various senior HR leadership roles in the industry.
News
Other IT executives who recently changed jobs as well: Barnes Matt, Griek John, Kuhn Pat, Malot Solange, Viswanathan Anil, Maiworm Sergio, Jo Chris, Ferris Suzanne, Shaberly Jason, Weisinger Rick, Gilbert Stephen
You can find the full directory of IT executives here.
How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.